Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la base de données des Annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
Ibafloxacin I DEC / 13
Ibandronic acid or its salts I DEC / 13
Ibogaine or its salts or derivatives or analogues I MAY / 17
Ibrutinib or its salts I DEC / 14
Ibuprofen or its salts

For veterinary use.

I DEC / 13
Ibuprofen or its salts

For human use - except when sold in an oral dosage form that provides 400 mg or less per dosage unit or in a modified-release oral dosage form that provides 600 mg or less per dosage unit.

I AUG / 16
Ibuprofen or its salts. when sold in an immediate release dosage form containing 400 mg or less per oral dosage unit (in package sizes exceeding 18,000 mg) III FEB / 12
Ibuprofen or its salts..

when sold in a modified-release oral dosage form that provides 600 mg or less per dosage unit

III AUG / 16
Ibuprofen or its salts... when sold in an immediate release dosage form containing 400 mg or less per oral dosage unit (in package sizes of up to 18,000 mg) U FEB / 12
Ibutilide or its salts or derivatives I DEC / 13
Icatibant or its salts

Including but not limited to Icatibant acetate.

I AUG / 14
Icosapent ethyl

For veterinary use.

I FEB / 20
Icosapent ethyl

For human use: when sold or recommended to reduce the risk of cardiovascular events in statin-treated patients with elevated triglycerides.  

I FEB / 20
Idarubicin or its salts I DEC / 13
Idarucizumab I AUG / 16
Idebenone I DEC / 13
Idelalisib I MAY / 15
Idoxuridine I DEC / 13
Idursulfase I DEC / 13
Ifosfamide I DEC / 13
Imatinib or its salts I DEC / 13
Imidapril or its salts I DEC / 13
Imiglucerase I DEC / 13
Imipramine or its salts I DEC / 13
Imiquimod or its salts I DEC / 13
Immune globulin products I FEB / 02
Immunogenic substances

When recommended for sublingual use, including but not limited to: anthoxanthium odoratum L. (sweet vernal grass), betula verrucosa (white birch), dactylis glomerata L. (cocksfoot), lolium perenne L. (rye grass), phleum pratense L. (timothy grass), poa pratense L. (meadow grass).

I JUL / 20
Indacaterol or its salts or derivatives I DEC / 13
Indapamide or its salts I DEC / 13
Indinavir or its salts I DEC / 13
Indomethacin I DEC / 13
Infliximab I DEC / 13
Influenza vaccine II DEC / 98
Ingenol mebutate or its derivatives I DEC / 13
Inhaled human insulin I DEC / 13
Inosiplex I DEC / 13
Inotersen or its salts I NOV / 18
Inotuzumab ozogamicin I MAY / 18
Insulin II SEP / 98
Interferon I DEC / 13
Iodinated glycerol II SEP / 98
Iodine and its salts and derivatives except topical preparations or in oral doses of 1 mg or less per day II DEC / 98
Iodochlorhydroxyquin for topical use II SEP / 98
Iodochlorohydroxyquin

For veterinary use.

I DEC / 13
Iodochlorohydroxyquin

For human use - except in preparations for topical use on the skin.

I DEC / 13
Ipecac and its extracts and derivatives when used as an emetic II OCT / 98
Ipilimumab I DEC / 13
Ipratropium or its salts I DEC / 13
Iproniazid or its salts I DEC / 13
Irbesartan or its salts I DEC / 13
Irinotecan or its salts I DEC / 13
Iron and its salts and derivatives in preparations with more than 30 mg elemental iron per solid dosage unit or 5 mL oral liquid II SEP / 98
Iron derivatives

For human use - including but not limited to ferumoxytol, iron isomaltoside 1000, for parenteral use only.

I DEC / 13
Iron derivatives

For veterinary use - including but not limited to ferumoxytol, for all routes of administration but parenteral.

I DEC / 13
Isatuximab I JUL / 20
Isavuconazole or its salts I FEB / 19
Isocarboxazid or its salts I DEC / 13
Isoflurane I DEC / 13
Isoniazid I DEC / 13
Isopropamide and its salts I SEP / 98
Isopropyl myristate in concentration of 50%

for use in the treatment of head lice

III JUL / 07
Isoproterenol (Isoprenaline) or its salts I DEC / 13
Isosorbide and its salts I SEP / 98
Isotretinoin or its salts I DEC / 13
Isoxsuprine or its salts I DEC / 13
Isradipine or its salts I DEC / 13
Itraconazole or its salts I DEC / 13
Ivabradine or its salts or derivatives I FEB / 17
Ivacaftor or its derivatives I DEC / 13
Ixazomib or its derivatives I NOV / 16
Ixekizumab I AUG / 16

71 résultats


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act